Pages

19830830

Shop For AXIS LABS CREATINE ETHYL ESTER 120 CAPS


Merchant Name : House Of Nutrition


( Price , shipping and availability may change at any time )


SalePrice : $19.96








AXIS LABS CREATINE ETHYL ESTER 120 CAPS


Loading,cramping,bloating - Creatine Ethyl Ester HCl is an exceptionally soluble form of creatine resulting in advanced absorption,increased bioavailability,and stability! AXIS LABS CREATINE ETHYL ESTER 120 CAPS Description: You may already know that creatine increases ATP (adenosine triphosphate),the body's source of intramuscular strength. You may also know that dealing with creatine is a real pain. Instead of saturating your system in creatine and hoping for absorption,Creatine Ethyl Ester HCl penetrates the muscle cell resulting in substantially more functional creatine. This means no more loading,bloating,cramping or dehydration. Most users notice a difference in their first dose. (These statements have not been evaluated by the FDA. This product is not intended to diagnose,treat,cure or prevent any disease). Supplement Facts: Serving Size: 3 capsules Servings per container: 40 Amount Per Serving Creatine Ethyl Ester HCl 2250 mg Creatine Ethyl Ester 2250 mg Ingredients: Gelatin,Magnesium Stearate. Directions: As a dietary supplement,take 2-4 capsules twice daily. Workout Days: Take 2-4 capsules with 16 oz of water 15-30 minutes before workout. Take another 2-4 capsules with 16 oz water 15-30 minutes after workout. Non Workout Days: Take 2-4 capsules with 16 oz water with first meal. Take another 2-4 capsules with 16 oz water with meal 4-6 hours later. Store in a cool,dry place. Protect from heat,light,and moisture. Notes: Keep out of reach of children. This product is not intended for anyone under the age of 18. Consult your physician before using any dietary supplement. Do not take this product if you have any medical condition and/or are taking any prescription medication(s). Discontinue use if experiencing any adverse side effects.





AXIS LABS CREATINE ETHYL ESTER 120 CAPS

No comments:

Post a Comment